We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle (401897)

ARTG ID 401897

ARTG Name

SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle

Product name

SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle

ARTG Date

9 August 2023

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

medroxyprogesterone acetate

Licence category

RE

Licence status

A

Summary

Related information

SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Pfizer Australia Pty Ltd declaring $0 turnover in that period.
SAYANA PRESS medroxyprogesterone acetate 104 mg/0.65 mL suspension for injection ampoule with attached needle, Pfizer Australia Pty Ltd, CON-1151

4 August 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 4 August 2023 until 4 August 2025.